Yuki Gosei Kogyo Co., Ltd. (4531.T)
- Previous Close
309.00 - Open
305.00 - Bid 296.00 x --
- Ask 301.00 x --
- Day's Range
296.00 - 306.00 - 52 Week Range
275.00 - 359.00 - Volume
310,300 - Avg. Volume
122,433 - Market Cap (intraday)
6.46B - Beta (5Y Monthly) 0.66
- PE Ratio (TTM)
10.17 - EPS (TTM)
29.10 - Earnings Date May 15, 2024
- Forward Dividend & Yield 15.00 (5.07%)
- Ex-Dividend Date Mar 28, 2024
- 1y Target Est
--
Yuki Gosei Kogyo Co., Ltd. researches, develops, manufactures, and markets fine chemical products in Japan and internationally. It offers food additives, pharmaceuticals, and industrial and agricultural chemicals; and glycine, glycine compounds, nicotinic acid amide, isoniazid, drug intermediates, and cosmetic ingredients. The company also provides amino acid, pyridine, piperidine, silicon, and other compounds; DNA, nucleoside, and protamine; and active pharmaceutical ingredients. In addition, it engages in the contract manufacturing of pharmaceuticals and chemical products. Yuki Gosei Kogyo Co., Ltd. was founded in 1947 and is headquartered in Tokyo, Japan.
www.yuki-gosei.co.jpRelated News
Performance Overview: 4531.T
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4531.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4531.T
Valuation Measures
Market Cap
6.46B
Enterprise Value
11.17B
Trailing P/E
10.18
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.51
Price/Book (mrq)
0.55
Enterprise Value/Revenue
0.88
Enterprise Value/EBITDA
13.85
Financial Highlights
Profitability and Income Statement
Profit Margin
4.97%
Return on Assets (ttm)
2.37%
Return on Equity (ttm)
5.49%
Revenue (ttm)
12.75B
Net Income Avi to Common (ttm)
634M
Diluted EPS (ttm)
29.10
Balance Sheet and Cash Flow
Total Cash (mrq)
760M
Total Debt/Equity (mrq)
46.90%
Levered Free Cash Flow (ttm)
--
Company Insights: 4531.T
4531.T does not have Company Insights